11/01/2024
3:30 PM | ESSA Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/07/2024
2:00 PM | ESSA Pharma (Issuer)
Virsik Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/09/2024
1:03 PM | ESSA Pharma (Issuer)
Virsik Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/03/2024
5:57 PM | ESSA Pharma (Issuer)
Virsik Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/05/2024
6:00 AM | ESSA Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/05/2024
6:01 AM | ESSA Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2024
6:00 AM | ESSA Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
|
05/14/2024
6:01 AM | ESSA Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/06/2024
4:17 PM | ESSA Pharma (Issuer)
Virsik Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/25/2024
9:35 AM | ESSA Pharma (Issuer)
Glickman Richard M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/05/2024
5:16 PM | ESSA Pharma (Issuer)
Virsik Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/05/2024
2:02 PM | ESSA Pharma (Subject)
Virsik Peter (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/28/2024
11:34 AM | ESSA Pharma (Issuer)
Kantoff Philip W. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
11:35 AM | ESSA Pharma (Issuer)
Martin John Alexander (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
11:36 AM | ESSA Pharma (Issuer)
Merendino Lauren (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
11:38 AM | ESSA Pharma (Issuer)
Requadt Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
11:39 AM | ESSA Pharma (Issuer)
Sollis Gary (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
11:40 AM | ESSA Pharma (Issuer)
Thorell Marella (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
11:41 AM | ESSA Pharma (Issuer)
ZWEIFACH SANFORD S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
11:25 AM | Cesano Alessandra (Reporting)
ESSA Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
11:27 AM | ESSA Pharma (Issuer)
Parkinson David Ross (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
11:30 AM | ESSA Pharma (Issuer)
Virsik Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
11:31 AM | ESSA Pharma (Issuer)
Wood David S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
11:32 AM | BERGER FRANKLIN M (Reporting)
ESSA Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
11:33 AM | ESSA Pharma (Issuer)
Glickman Richard M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
4:18 PM | ESSA Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/05/2024
5:50 PM | ESSA Pharma (Issuer)
Virsik Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
6:05 AM | ESSA Pharma (Subject)
RTW INVESTMENTS, LP (Filed by)
| Form SC 13G | |
02/13/2024
6:01 AM | ESSA Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/13/2024
6:01 AM | ESSA Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
02/13/2024
5:04 AM | BB BIOTECH AG (Filed by)
ESSA Pharma (Subject)
| Form SC 13G/A | |
02/08/2024
10:29 AM | ESSA Pharma (Subject)
MORGAN STANLEY (Filed by)
| Form SC 13G | |
02/07/2024
10:29 AM | ESSA Pharma (Issuer)
Virsik Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2024
7:27 AM | ESSA Pharma (Issuer)
Virsik Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2024
8:15 AM | ESSA Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/23/2024
3:09 PM | ESSA Pharma (Subject)
Soleus Capital, LLC (Filed by)
| Form SC 13G/A | |
01/17/2024
7:57 PM | ESSA Pharma (Issuer)
Virsik Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/16/2024
12:41 PM | ESSA Pharma (Issuer)
Requadt Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/12/2024
2:50 PM | ESSA Pharma (Subject)
Gagnon Robert E. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2024
7:06 PM | ESSA Pharma (Issuer)
Virsik Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2023
8:57 PM | ESSA Pharma (Issuer)
Parkinson David Ross (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Crypto Crash Ahead? (27 Experts Weigh In) (Ad) Your Portfolio Could Be at RISK
Emergency summit reveals crypto could save you! Click here to reserve your spot at the emergency crypto summit now. |
12/12/2023
6:00 AM | ESSA Pharma (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
12/12/2023
6:01 AM | ESSA Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/24/2023
10:11 AM | ESSA Pharma (Issuer)
Wood David S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2023
5:22 PM | BERGER FRANKLIN M (Reporting)
ESSA Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/16/2023
4:45 PM | BERGER FRANKLIN M (Reporting)
ESSA Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/03/2023
8:44 PM | ESSA Pharma (Filer)
| Form 424B5 | |
